People Briefs: Ortho Clinical, Thoratec, Pentax Medical, Vygon
This article was originally published in The Gray Sheet
Executive Summary
Ortho Clinical Diagnostics names new board members. Thoratec appoints president, International. Pentax Medical taps new CMO, COO. Vygon Group appoints VP of research & development.
You may also be interested in...
Hologic Increases Bets In Lab Space With $3.7 Bil. Gen-Probe Purchase
Lab diagnostic products will actually account for a larger portion of Hologic’s business post-acquisition than the firm’s core mammography, ultrasound and magnetic resonance imaging offerings.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.